Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
Daily Ingestion of a Multi-Allergen Food Supplement by Infants: Clinical Symptoms, Reactions, and Acceptability - A Randomized Trial
1 other identifier
interventional
705
1 country
1
Brief Summary
The purpose of the study is to test a food supplement to:
- Show that the food supplement is well tolerated and safe to feed to infants;
- Find out how often parents/caregivers feed their infants the food supplement;
- Find out how parents/caregivers usually add the food supplement to infants' regular solid or liquid food; and
- Learn what aspects of the food supplement are more or less attractive to infants and to parents/caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 9, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 9, 2017
CompletedFirst Submitted
Initial submission to the registry
September 10, 2018
CompletedFirst Posted
Study publicly available on registry
September 12, 2018
CompletedMarch 13, 2019
March 1, 2019
4 months
September 10, 2018
March 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Allergic-type reaction
difference between the proportion of infants with allergic-type reaction within 2 hours of ingestion in the food supplement versus placebo arm
1month
Secondary Outcomes (1)
Symptom
1 month
Study Arms (2)
Food Supplement
EXPERIMENTALInfants who received the active food supplement powder
Placebo
PLACEBO COMPARATORInfants who received the placebo powder
Interventions
A powder blend of 16 common allergenic proteins (\[oat, milk, egg, sesame, wheat\] \[almond cashew, hazelnut, peanut, pecan, pistachios, soy, walnut\] \[cod, shrimp, salmon\]) combined with 400 IU of Vitamin D3
Eligibility Criteria
You may qualify if:
- healthy infants, ≥ 5 months but \< 11 months of age whose parent/caregiver can provide, in English, consent, understand instructions and complete a daily diet diary for their child, answer questions about how much and in what food they mix the Food supplement, and report any reaction or adverse event. Pregnant women will not be excluded if they have a child who is eligible for the study.
You may not qualify if:
- \- Any parent/caregiver who cannot provide consent.
- Any parent/caregiver who cannot understand or write English.
- A parent/caregiver who is in prison.
- Any infant who
- Has a previous or current diagnosis of food allergy, made by a board-certified allergy and immunology specialist;
- Was born before 37 weeks of pregnancy (premature birth);
- Has severe eczema, as determined by two parent/caregiver questions:
- During the past 6-11months, have you been told by a doctor or other health professional that your infant has eczema or any kind of skin allergy? (National Health Interview Survey, 2012) If yes, go to Question 2.
- Would you describe (his/her) eczema or skin allergy as mild, moderate, or severe? (National Survey of Children's Health, 2007) If described as severe, infant is excluded.
- Has a current serious, chronic condition, as measured by:
- Does you infant have a health condition that has lasted for more than three (3) months? If yes, go to Question 2.
- Has your infant been hospitalized more than 2 times since birth for this condition? If yes to Question 1 and 2, infant is excluded.
- If a parent/caregiver has multiple birth infants (e.g., twins), only one eligible infant will be selected.
- Any person who works for Before Brands or who has a family member working for Before Brands.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jane L Holl
Chicago, Illinois, 60614, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jane L Holl, MD MPH
Professor of Pediatrics, Feinberg School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Parents received packets of the powder to be fed from their infant directly from the manufacturer.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Center for Healthcare Studies
Study Record Dates
First Submitted
September 10, 2018
First Posted
September 12, 2018
Study Start
June 18, 2017
Primary Completion
October 9, 2017
Study Completion
October 9, 2017
Last Updated
March 13, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share
Demographic data about the study participants Outcomes of the study